These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 3609634)
21. [Pathogenesis and therapy of cholelithiasis]. Kaess H Med Welt; 1973 Dec; 24(50):1994-6. PubMed ID: 4776224 [No Abstract] [Full Text] [Related]
22. Increased activity in the biliary Con A-binding fraction accounts for the difference in crystallization behavior in bile from Chilean gallstone patients compared with Dutch gallstone patients. Miquel JF; Van Der Putten J; Pimentel F; Mok KS; Groen AK Hepatology; 2001 Feb; 33(2):328-32. PubMed ID: 11172333 [TBL] [Abstract][Full Text] [Related]
23. Physical activity, biliary lipids, and gallstones in obese subjects. Chuang CZ; Martin LF; LeGardeur BY; Lopez A Am J Gastroenterol; 2001 Jun; 96(6):1860-5. PubMed ID: 11419840 [TBL] [Abstract][Full Text] [Related]
24. [Cholesterol: essential for life but harmful]. Miettinen TA Duodecim; 1984; 100(23-24):1586-99. PubMed ID: 6519003 [No Abstract] [Full Text] [Related]
25. Evidence that a diminished bile acid pool precedes the formation of cholesterol gallstones in man. Bell CC; Vlahcevic ZR; Prazich J; Swell L Surg Gynecol Obstet; 1973 Jun; 136(6):961-5. PubMed ID: 4703476 [No Abstract] [Full Text] [Related]
26. Lipid metabolism in the development of cholesterol gallstones in hamsters. I. Study on the relationship between serum and biliary lipids. Kajiyama G; Kubota S; Sasaki H; Kawamoto T; Miyoshi A Hiroshima J Med Sci; 1980 Sep; 29(3):133-41. PubMed ID: 7429880 [No Abstract] [Full Text] [Related]
30. [Pathogenesis of biliary lithiasis]. Gérolami A Arch Fr Mal App Dig; 1973 Mar; 62(2):157-9. PubMed ID: 4727285 [No Abstract] [Full Text] [Related]
31. Monoconjugated bilirubin as a possible factor in cholesterol gallstone pathogenesis. Lesma A; Monti D; Mezzabotta M; Cristaldi M; Danelli PG; Rovati M; Taschieri AM Minerva Chir; 1997 Jun; 52(6):771-5. PubMed ID: 9283186 [TBL] [Abstract][Full Text] [Related]
32. Pathobiology of cholesterol gallstone disease: from equilibrium ternary phase diagram to agents preventing cholesterol crystallization and stone formation. Portincasa P; Moschetta A; Calamita G; Margari A; Palasciano G Curr Drug Targets Immune Endocr Metabol Disord; 2003 Mar; 3(1):67-81. PubMed ID: 12570727 [TBL] [Abstract][Full Text] [Related]
33. Cholesterol gallstone formation and its regression in prairie dogs. Chang SH; Ho KJ; Taylor CB Arch Pathol; 1973 Dec; 96(6):417-26. PubMed ID: 4784872 [No Abstract] [Full Text] [Related]
34. Biliary cholesterol hypersecretion in gallstone-susceptible mice is associated with hepatic up-regulation of the high-density lipoprotein receptor SRBI. Fuchs M; Ivandic B; Müller O; Schalla C; Scheibner J; Bartsch P; Stange EF Hepatology; 2001 Jun; 33(6):1451-9. PubMed ID: 11391534 [TBL] [Abstract][Full Text] [Related]
35. Cholesterol metabolism and serum and biliary noncholesterol sterols in gallstone patients during simvastatin and ursodeoxycholic acid treatments. Miettinen TE; Kiviluoto T; Taavitsainen M; Vuoristo M; Miettinen TA Hepatology; 1998 Mar; 27(3):649-55. PubMed ID: 9500689 [TBL] [Abstract][Full Text] [Related]
37. Ground squirrel model for cholelithiasis: role of epithelial glycoproteins. MacPherson BR; Pemsingh RS Microsc Res Tech; 1997 Oct; 39(1):39-55. PubMed ID: 9329018 [TBL] [Abstract][Full Text] [Related]
38. Biliary lipid secretion before and after cholecystectomy in American Indians with cholesterol gallstones. Adler RD; Metzger AL; Grundy SM Gastroenterology; 1974 Jun; 66(6):1212-7. PubMed ID: 4829123 [No Abstract] [Full Text] [Related]